Pretzel Therapeutics News and Activities

Acquisition, funding and merger involving Pretzel Therapeutics.

• Pretzel Therapeutics has announced the acquisition of Rome Therapeutics  (posted on January 19 2026).

View the org chart displaying its 22 main executives

Most searched biographies at Pretzel Therapeutics

• Jay Parrish, Chief Executive Officer and Chairman of the Board
• Anika Gupta, Director
• Kristina Burow, Director

Popular executive movements at Pretzel Therapeutics

• Ashish Dugar has joined the company as Chief Development Officer  (posted on September 8 2025).

Create your alert
to follow the executive moves at Pretzel Therapeutics.

Pretzel Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Pretzel Therapeutics

• Pretzel advances mitochondrial therapy with PX578 Phase 1 trial
• Small Molecule Restores Mitochondrial Function in POLG Disorders
• News » Pretzel Therapeutics

Social media about Pretzel Therapeutics

• Pretzel Therapeutics on Wikipedia, Google News & Yahoo Finance
• Pretzel Therapeutics on LinkedIn, X (Twitter) & YouTube